Frank A. Oski Memorial Lectureship
The purpose of the annual Frank A. Oski Memorial Lectureship is to honor Dr. Oski's many contributions to the field of pediatric hematology/oncology and ensure a younger generation of pediatric hematology/oncology specialists remains aware of his legacy. The lectureship is awarded to an outstanding clinical or laboratory investigator in pediatric hematology/oncology whose cutting-edge research is of the caliber of the investigations made by Dr. Oski.
Nominations are no longer being accepted for the 2017 award. Nominations for the 2018 award will open in late summer.
Alexis A. Thompson, MD MPH
Ann & Robert H. Lurie Children's Hospital of Chicago
The Frank A. Oski Memorial Lectureship is presented annually to an internationally known and accomplished clinical or research scientist with an MD, PhD or MD/PhD degree, and while it is not required, ideally they would be a board certified pediatric hematology/oncology specialist. The recipient should be in early or mid-career (generally under 50 years of age), be known as an excellent speaker and investigator, and must agree to present a 35-45 minute state-of-the-art lecture describing his/her research at the ASPHO Annual Meeting. The recipient need not be a member of ASPHO.
Nomination and Selection Procedure:
Nominations for the Frank A. Oski Memorial Lectureship are solicited from ASPHO members and other leaders in the field, and must include a letter of nomination and a current CV. Nominations will be compiled by the Awards Committee, which will recommend a recipient to the Board of Trustees.
Recognition and Expense Reimbursement:
The Oski recipient will receive complimentary meeting registration, round-trip economy airfare, two nights in the meeting hotel, a $750 honorarium, and an award plaque to be presented prior to the lecture.
2015 Stephan A. Grupp, MD PhD
Children's Hosital of Philadelphia
Novel Therapies for Pediatric Leukemia
2014 Scott A. Armstrong, MD PhD
Memorial Sloan-Kettering Cancer Center
New York, NY
MLL-Rearranged Leukemias: Stem Cells, Histone Modifications, and New Therapies
2013 Jorge DiPaola, MD
Children's Hospital Colorado
Platelets and Von Willebrand Factor: An Axis of Good and (Sometimes) Evil
2012 Lillian Sung, MD PhD
Hospital for Sick Children
Toronto, ON, Canada
Decision Making in Pediatric Oncology: Evaluation and Incorporation of Patient and Parent Preferences
2011 Mignon Loh, MD
University of California, San Francisco
San Francisco, CA
Lessons Learned from Studying Children with Hematopoietic Malignancies
2010 Smita Bhatia, MD MPH
City of Hope National Medical Center
Pediatric Cancer Survivorship: Some Well-Traveled Paths—Yet Miles to Go...
2009 Donald Small, MD PhD
FLT3: Biology and Targeting in Leukemia
2008 Todd Golub, MD
Genomic Signatures and Cancer
2007 John Maris, MD
Translating our Evolving Knowledge of Neuroblastoma Biology to Patients with the Disease
2006 David Williams, MD
Cell-Cell Interactions in the Bone Marrow: How Basic Studies in Stem Cell Biology Informed New Therapeutics in Cancer and Gene Therapy
2005 Thomas Look, MD
The Emerging Genetics of T-Cell ALL in Children and Adolescents
2004 Russell Ware, MD PhD
Hydroxyurea for Children with Sickle-cell Disease: Fact, Fiction, and Fantasy
2003 Stuart Orkin, MD
Journey from Thalassemia to Stem Cells
2002 George Dover, MD
Pediatric Hematology/Oncology: A Look into the Future